Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Short-term Investments (2022 - 2023)

Neuroone Medical Technologies (NMTC) has disclosed Short-term Investments for 2 consecutive years, with $995432.0 as the latest value for Q1 2023.

  • For the quarter ending Q1 2023, Short-term Investments changed N/A year-over-year to $995432.0, compared with a TTM value of $995432.0 through Mar 2023, changed N/A, and an annual FY2022 reading of $3.0 million, changed N/A over the prior year.
  • Short-term Investments was $995432.0 for Q1 2023 at Neuroone Medical Technologies, down from $3.0 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $3.0 million in Q3 2022 and bottomed at $995432.0 in Q1 2023.